- Home
- MCR vs IMRX Comparison
MCR vs IMRX Comparison
Compare MCR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- IMRX
- Stock Information
- Founded
- MCR 1989
- IMRX 2008
- Country
- MCR United States
- IMRX United States
- Employees
- MCR N/A
- IMRX N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MCR Finance
- IMRX Health Care
- Exchange
- MCR Nasdaq
- IMRX Nasdaq
- Market Cap
- MCR 265.5M
- IMRX 232.9M
- IPO Year
- MCR N/A
- IMRX 2021
- Fundamental
- Price
- MCR $6.54
- IMRX $7.86
- Analyst Decision
- MCR
- IMRX Strong Buy
- Analyst Count
- MCR 0
- IMRX 4
- Target Price
- MCR N/A
- IMRX $13.75
- AVG Volume (30 Days)
- MCR 66.7K
- IMRX 1.2M
- Earning Date
- MCR 01-01-0001
- IMRX 11-12-2025
- Dividend Yield
- MCR 8.52%
- IMRX N/A
- EPS Growth
- MCR N/A
- IMRX N/A
- EPS
- MCR 0.38
- IMRX N/A
- Revenue
- MCR N/A
- IMRX N/A
- Revenue This Year
- MCR N/A
- IMRX N/A
- Revenue Next Year
- MCR N/A
- IMRX N/A
- P/E Ratio
- MCR $16.61
- IMRX N/A
- Revenue Growth
- MCR N/A
- IMRX N/A
- 52 Week Low
- MCR $5.63
- IMRX $1.10
- 52 Week High
- MCR $6.70
- IMRX $9.37
- Technical
- Relative Strength Index (RSI)
- MCR 72.06
- IMRX 70.79
- Support Level
- MCR $6.35
- IMRX $5.17
- Resistance Level
- MCR $6.43
- IMRX $9.37
- Average True Range (ATR)
- MCR 0.05
- IMRX 0.75
- MACD
- MCR 0.01
- IMRX 0.26
- Stochastic Oscillator
- MCR 80.43
- IMRX 65.05
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.